These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2780658)

  • 1. Photodynamic therapy Tis and T1 transitional carcinoma of the bladder.
    Javadpour N
    Prog Clin Biol Res; 1989; 303():471-8. PubMed ID: 2780658
    [No Abstract]   [Full Text] [Related]  

  • 2. Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ.
    Hisazumi H; Naito K; Uchibayashi T; Hirata A; Komatsu K
    Scand J Urol Nephrol Suppl; 1991; 138():161-5. PubMed ID: 1785000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy.
    Nseyo UO
    Urol Clin North Am; 1992 Aug; 19(3):591-9. PubMed ID: 1386168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.
    Prout GR; Lin CW; Benson R; Nseyo UO; Daly JJ; Griffin PP; Kinsey J; Tian ME; Lao YH; Mian YZ
    N Engl J Med; 1987 Nov; 317(20):1251-5. PubMed ID: 2959863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photodynamic therapy (PDT) of bladder cancer. Report of 21 cases].
    Xie JG
    Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):113-5. PubMed ID: 4006674
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photodynamic procedures in urology].
    Jocham D
    Urologe A; 1994 Nov; 33(6):547-52. PubMed ID: 7817455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of photodynamic therapy in the treatment of refractory carcinoma in situ].
    Benson RC
    Urologe A; 1991 May; 30(3):158-61; discussion 161-2. PubMed ID: 1871933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
    Benson RC
    Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance.
    Griffiths TR; Charlton M; Neal DE; Powell PH
    J Urol; 2002 Jun; 167(6):2408-12. PubMed ID: 11992047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Integral photodynamic therapy of multifocal bladder cancer. Initial clinical experiences].
    Jocham D; Staehler G; Baumgartner R; Unsöld E
    Urologe A; 1985 Nov; 24(6):316-9. PubMed ID: 4090126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of bladder cancer: current progress.
    Murphy GP
    N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
    [No Abstract]   [Full Text] [Related]  

  • 14. Unmanageable fever and granulomatous renal mass after intracavitary upper urinary tract bacillus Calmette-Guerin therapy.
    Tavolini IM; Gardiman M; Benedetto G; Bassi P
    J Urol; 2002 Jan; 167(1):244-5. PubMed ID: 11743318
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ.
    da Silva FC
    Prog Clin Biol Res; 1989; 303():401-10. PubMed ID: 2675001
    [No Abstract]   [Full Text] [Related]  

  • 16. [Photodynamic therapy for superficial bladder tumors].
    Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):1119-24. PubMed ID: 11769076
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
    Kurth KH; Sylvester R; de Pauw M; ten Kate F
    Prog Clin Biol Res; 1989; 310():125-45. PubMed ID: 2672012
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder calcifications after photodynamic therapy: analysis of a rare complication.
    Walther MM; Eanes ED; Delaney TF; Travis WD
    Urology; 1996 Jun; 47(6):831-5. PubMed ID: 8677572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.